Victory Capital Management
IMVT icon

Victory Capital Management’s Immunovant IMVT Stock Holding History

Victory Capital Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.44M Buy
72,228
+62,867
+672% +$2.48M ﹤0.01% 1602
2026
Q2 		$361K Sell
9,361
-253
-3% -$7.71K ﹤0.01% 2131
2026
Q1 		$239K Buy
9,614
+1,077
+13% +$27.9K ﹤0.01% 2165
2025
Q4 		$217K Buy
+8,537
New +$190K ﹤0.01% 2186
2025
Q3 		– Sell
-31,507
Closed -$504K – 2480
2025
Q2 		$504K Buy
+31,507
New +$476K ﹤0.01% 2058
2025
Q1 		– Sell
-45,100
Closed -$1.12M – 2501
2024
Q4 		$1.12M Sell
45,100
-290,260
-87% -$8.23M ﹤0.01% 1757
2024
Q3 		$9.6M Buy
335,360
+22,990
+7% +$678K 0.01% 1120
2024
Q2 		$8.25M Sell
312,370
-6,631
-2% -$189K 0.01% 1132
2024
Q1 		$10.3M Sell
319,001
-6,533
-2% -$238K 0.01% 1056
2023
Q4 		$13.7M Sell
325,534
-47,237
-13% -$1.74M 0.01% 921
2023
Q3 		$14.3M Sell
372,771
-205,364
-36% -$4.64M 0.02% 882
2023
Q2 		$11M Sell
578,135
-87,650
-13% -$1.63M 0.01% 1007
2023
Q1 		$10.3M Buy
+665,785
New +$11.6M 0.01% 1017
2021
Q1 		– Sell
-6,888
Closed -$318K – 2761
2020
Q4 		$318K Buy
6,888
+1,073
+18% +$49.6K ﹤0.01% 2266
2020
Q3 		$205K Buy
+5,815
New +$175K ﹤0.01% 2281

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Victory Capital Management's IMVT Position: Q3 2026 in Review

Victory Capital Management increased its Immunovant (IMVT) stake by 672% in Q3 2026, buying an estimated $2.48M and bringing the position to 72,228 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #1602.

Victory Capital Management first reported a position in IMVT in Q3 2020 and has held it in 15 quarters since. The position peaked at $14.3M in Q3 2023. 101 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Victory Capital Management held 72,228 shares of Immunovant worth $2.44M as of Q3 2026.
  • Victory Capital Management bought 62,867 Immunovant shares in Q3 2026, an estimated $2.48M.
  • Immunovant made up ﹤0.01% of Victory Capital Management's portfolio in Q3 2026, its #1602 holding.
  • Victory Capital Management first reported a position in Immunovant in Q3 2020 and has held it in 15 quarters since.
  • Victory Capital Management's Immunovant position peaked at $14.3M in Q3 2023.
  • 101 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Victory Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.